Major Initiative By Pharma Industry
Use renewable sources of energy sources for Manufacturing
Prioritize materials and services with a lower environmental
effect
Design drugs and packaging to be recyclable
Consider innovations to reduce water usage and waste.
CIPLA CURRENT ESG STATUS
•The company emerged as a ‘Champion’ across all three pillars
of Environmental, Social and Governance through its advanced
initiatives. Cipla’s reduction of its scope 1 & 2 GHG emissions,
water usage, and waste generation from their operations in FY22
were outstanding facets under its environmental stewardship.
Under social and community-building initiatives, Cipla ensured a
supply of necessary drugs for non- communicable diseases, as
outlined under WHO’s essential medicines. Apart from its
diversity & inclusion initiatives, Cipla also fared well given its
strong measures on compliance, transparency and setting wide-
ranging multi-stakeholder
Notable Initiative By MNC Pharma
•The Pharma Block team was selected based on their
innovative work on “Sustainable Manufacturing Process for
Commercial and Developmental Stage Intermediates through
Two Consecutive Flow Reactions using Micro-Packed Bed
Technology.”
Source – ACS
chemistry of Life.
•. Boehringer Ingelheim Rank highest among pharma
companies known for its Alva in Environment measures ,
pointing to its switch to Wind Energy, manufacturing sites where
it makes vaccine for animals ,
Source-Fierce Pharma
Source – Cipla ESG report 2023
•Application of plasma gasification technology in
SWOT ANALYSIS
circumventing the medical waste, Converting Waste
into Syngas STRENGTH
•Pharmaceutical waste can be converted into syngas WEAKNESS
through a process called gasification. Gasification involves
the thermal decomposition of organic materials at high Syngas can be
temperatures in the presence of a controlled amount of
oxygen or steam. This process converts the waste into a produced from The conversion
mixture of gases, primarily carbon monoxide (CO) and
hydrogen (H₂), known as syngas..
various renewable processes for
sources, including syngas into
•
library of medicine
Source-National Pharma waste, pharmaceutical-
•Also Utilizing syngas can grade chemicals
potentially reduce can be complex
raw material costs, and require
especially if derived advanced
from waste technology.
Opportunity
products. THREAT
There is significant
potential for
Fluctuations in the
innovation in
economy can
developing new
impact investment
processes and
in new
technologies for
technologies and
syngas utilization in
processes.
pharmaceuticals.
